COMP <GO>
CMCO vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Columbus McKinnon Corporation (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: CMCO 2
— TMO 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TMO
LAST: $15.25 (+1.26%) • MKT CAP: $440.2M
roic
-10.60%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CMCO VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CMCO | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -10.60% | 9.30% | -19.90 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.40% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -10.00% | 17.40% | -27.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | -19.20% | 15.10% | -34.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 23.90% | 3.90% | +20.00 | CMCO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.83% | 0.24% | +1.59 | CMCO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.22 | 4.50 | -3.28 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.9 | 62.9 | -17.04 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $440.2M | $262.22B | -$261.78B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CMCO REV | TMO REV | CMCO GROSS % | TMO GROSS % | CMCO FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.19B | $44.56B | 30.1% | — | -$164.1M | $6.29B |
| FY 2024 | $963.0M | $42.88B | 33.8% | — | $24.2M | $7.27B |
| FY 2023 | $1.01B | $42.86B | — | — | $67.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CMCO // BETA —
TMO // BETA 0.94